Bristol-Myers Squibb Company News
Bristol Myers Squibb Shakes Up Key Biotech Battleground
The FDA approval of Sotyktu for psoriasis has both ignited and dampened prospects for smaller biotech stocks.
Bristol Myers Squibb Stock: Here's the Key Breakout Level to Watch
Bristol Myers Squibb received good news from the FDA, but only enough to put a key resistance level in play. Here's the level it needs to clear.
Stock Market Today - 9/12: Stocks End Higher Amid Dollar Retreat With Inflation Data In Focus
Stocks finished higher after snapping a three-week losing streak as the dollar continues to slide against its global currency peers.
Bristol Myers Stock Surges After FDA Approves New Plaque Psoriasis Treatment; Amgen Slides
“We believe Sotyktu is a breakthrough in the treatment of patients suffering from moderate-to-severe plaque psoriasis," said Bristol Myers' chief medical officer Samit Hirawat.
This Small-Cap Biotech is a Sneaky Play on Next-Gen Drugs
Selecta Biosciences is one of the most mature companies in an area attracting the attention of industry titans.
Bristol Myers Stock Slumps After Mixed Data From Stroke Drug Trial
"Secondary strokes continue to be a serious health risk for stroke patients and we believe these data demonstrated the potential of milvexian to address a key unmet need in this population," Bristol Myers said.
Mr. Big Short Michael Burry Makes a Shocking Decision
The investor, who successfully bet against the U.S. mortgage market before the 2008 financial crisis, has just made a huge gamble.
Stock Market Today - 7/27: Stocks Surge After Dovish Fed Decision; Big Tech Powers Market Boost
A dovish Fed, alongside stronger-than-expected outlooks from Microsoft and Google, have stocks trading firmly higher into the Wednesday close.
Bristol Myers Q2 Earnings Top Street Forecasts On Solid Eliquis and Opdivo Sales
Solid cancer and blood clot treatment sales, as well as a smaller-than-forecast decline for Revlimid, helped deliver a top and bottom line beat for drugmaker Bristol Myers.
Stocks Higher, Fed Rate Decision, Microsoft, Google and Visa In Focus - Five Things To Know
Stock futures higher as fed decision looms; Powell comments in focus as markets look for new rate signals; Microsoft leaps as bullish outlook offsets Q4 earnings miss; Google powers higher as earnings defy ad market gloom and Visa beats Q2 earnings forecast, sees no signs of spending slowdown.
Tips for Retirees to Deal with Falling Stocks and Bonds
The markets' slide particularly hurts retirees, who may have to sell some of their stocks and bonds to finance spending.
Alphabet CEO Pichai Continues to Sound Alarm About the Economy
The parent company of Google and Youtube is preparing for a sharp deterioration in the health of the economy.